Stockreport

Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders [Yahoo! Finance]

Carisma Therapeutics, Inc.  (CARM) 
PDF June 13, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM ) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering [Read more]